GFGiovanni Frongia

Giovanni Frongia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Giovanni Frongia has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • Arianeb Mehrabi

    Department of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany

    7 shared publications
  • P. Günther

    Division of Pediatric Surgery, Department of General, Visceral and Transplantation Surgery University Hospital Heidelberg Im Neuenheimer Feld 430 69120 Heidelberg Germany

    4 shared publications
  • Patrick Günther

    Division of Pediatric Surgery, Department of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Germany

    4 shared publications
  • Arianeb Mehrabi

    Department of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Germany

    3 shared publications
  • Franziska Christiane Steffens

    Division of Pediatric Surgery, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany

    2 shared publications
  • Golnaz Emami

    Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany

    2 shared publications

Latest Publications

  • Open Access

    Impact of previous abdominal surgery on the outcome of fundoplication for medically refractory gastroesophageal reflux disease in children and young adults

    by Franziska Christiane Steffens, Marcus Dahlheim, Patrick Günther, Arianeb Mehrabi, Raphael N. Vuille-Dit-Bille, Ulrich Klaus Fetzner, Berthold Gerdes, Giovanni Frongia

    Summary: Importance: Fundoplication (FP) is a well-established surgical treatment for gastroesophageal reflux disease (GERD) refractory to medical therapy in children and young adults. During FP, previous abdominal surgery (PAS) can impair the patient’s outcome by causing technical difficulties and increasing intra- and postoperative complication rates. Objective: The aim of this study was to determine the impact of PAS on the short- and long-term outcome following FP for refractory GERD in a cohort of patients aged < 23 years. Methods: We retrospectively analyzed 182 patients undergoing a total of 201 FP procedures performed at our university center for pediatric surgery from February 1999 to October 2019. Pre-, intra-, and postoperative variables were recorded and their impact on the rate of intraoperative complications and revision FP (reFP) was analyzed. Results: A total of 201 FP procedures were performed on 182 patients: 119 (59.2%) as Thal-FP (180° anterior wrap) and 82 (40.8%) as Nissen-FP (360°circular wrap; 67.2% laparoscopic, 32.8% open, 8.9% conversion). The presence of PAS (95 cases, 47.3%) was associated with significantly longer operative times for FP (153.4 ± 53.7 vs.126.1 ± 56.4 min, p = 0.001) and significantly longer hospital stays (10.0 ± 7.0 vs. 7.0 ± 4.0 days, p < 0.001), while the rates of intraoperative surgical complications (1.1% vs. 1.9%, p = 1.000) and the rate re-FP in the long term (8.4% vs. 15.1%, p = 0.19) during a follow-up period of 53.4 ± 44.5 months were comparable to the group without PAS. Conclusion: In cases of PAS in children and young adults, FP for refractory GERD might necessitate longer operative times and longer hospital stays but can be performed with surgery-related short- and long-term complication rates comparable to cases without PAS.

  • Delayed Surgery for Perforated Appendicitis is Feasible in Children Without Compromising the Outcome in Selected Cases

    by G. Frongia, F. Dostal, L. Ziebell, N. R. Vuille‐Dit‐Bille, T. Müller, J. P. Schenk, A. Mehrabi, P. Günther

    Background and aim: The relationship between time to surgery and risk of postoperative complications and re‐intervention has not been conclusively investigated in pediatric perforated appendicitis (PA). The aim of this study was to determine whether time to appendectomy (TTA) is a risk factor for postoperative complications and re‐intervention in a cohort of children undergoing appendectomy for PA.Methods: A total of 254 children (age: 8.7 ± 3.7 years) undergoing appendectomy for PA were retrospectively evaluated and stratified into Group I–III according to the Clavien‐Dindo classification for postoperative complications (Group I n = 218, 86%; Group II n = 7, 3%; Group III n = 29, 11%).Results: The TTA was comparable between all groups (group I: 8.8 ± 9.2 h; group II: 7.8 ± 5.3 h; group III: 9.5 ± 9.6 h; overall: 8.8 ± 9.1 h; p = 0.885). A C‐reactive protein (CRP) value at admission of ≥128.6 mg/l indicated a higher risk for developing Grade II complications with no need for re‐intervention (OR: 3.963; 95% CI: 1.810–8.678; p = 0.001) and Grade III complications with the need for re‐intervention (OR: 3.346; 95% CI: 1.456–7.690; p = 0.004). This risk was independent of the TTA (OR: 1.007; 95% CI: 0.980–1.035; p = 0.613).Conclusions: Appendectomy can be delayed by an average time delay of about 9 h in children with PA without increasing the risk of postoperative complications and re‐intervention, also in patients at high risk defined by the initial CRP level ≥ 128.6 mg/l. This data may support the correct risk‐adjusted scheduling of surgical interventions in times of limited capacity.


  • Diagnosis and Treatment of Gastroesophageal Reflux Disease in Childhood

    by Giovanni Frongia, Ulrich Klaus Fetzner, Raphael Nicolas Vuille-Dit-Bille, Stefan Gerhard Holland-Cunz

    In children with gastroesophageal reflux disease (GERD), conservative and surgical therapy options should be weighed up against each other and an individual solution tailored to the pediatric patient should be found. Decision should be made by an interdisciplinary team with representatives of all treating and caring disciplines together with the patient and his or her caregivers. The possibility of a surgical intervention and (if needed) the optimal time to operate should hereby be discussed with a (pediatric) surgeon at an early stage. Contrary to the possible fears of conservative disciplines. fundoplication for targeted surgical GERD therapy in childhood is usually carried out with few complications and, in well-defined cases. is associated with a positive outcome. The fulfillment of the decisive prerequisites for this is closely linked to the knowledge of the pediatric characteristics with regard to symptoms, diagnosis and therapy, the choice of the optimal surgical technique and a long-term secured follow-up care. The key points of these pediatric features are explained in detail below.


  • Open Access

    Abdominal Wall Defects—Current Treatments

    by Isabella N. Bielicki, Stig Somme, Giovanni Frongia, Stefan G. Holland-Cunz, Raphael N. Vuille-Dit-Bille

    Gastroschisis and omphalocele reflect the two most common abdominal wall defects in newborns. First postnatal care consists of defect coverage, avoidance of fluid and heat loss, fluid administration and gastric decompression. Definitive treatment is achieved by defect reduction and abdominal wall closure. Different techniques and timings are used depending on type and size of defect, the abdominal domain and comorbidities of the child. The present review aims to provide an overview of current treatments.


  • Quality of Life Improves Following Laparoscopic Hemifundoplication in Neurologically Non-Impaired Children with Gastroesophageal Reflux Disease: A Propensity Score-Matched Analysis

    by Giovanni Frongia, Daniel Weitz, Jan Bauer, Pascal Probst, Franziska Steffens, Dennis Pfisterer, Arianeb Mehrabi, Patrick Günther

    Quality of life (QOL) data following pediatric fundoplication for gastroesophageal reflux disease (GERD) are rare. Present study assessed the QOL in neurologically non-impaired children before and after laparoscopic hemifundoplication (LHF) in comparison to healthy controls. PedsQL™ questionnaires assessed data on gastrointestinal symptoms (GIS) and general well-being (GWB) were compared in a propensity score-matched analysis (60 patients’ pairs for time-point of surgery and 51 for follow-up). Preoperatively, the LHF group had more GIS (72.2 ± 53.9 vs. 38.8 ± 31.6; p < 0.001) and a lower GWB (16.7 ± 5.5 vs. 23.8 ± 3.5, p < 0.001) compared with controls. Postoperatively, GIS decreased significantly (74.3 ± 52.9 vs. 36.3 ± 33.5; p < 0.001) and the GWB was significantly higher (16.2 ± 6.0 vs. 20.8 ± 5.8; p < 0.001). GIS were similar in the LHF and control groups (39.1 ± 36.4 vs. 40.1 ± 31.0; p = 0.885) but GWB was lower in the LHF group than the control group (20.5 ± 6.3 vs. 23.4 ± 3.9; p = 0.009). QOL significantly improves after LHF in neurologically non-impaired children.


  • Recurrence rate of infantile hemangioma after oral propranolol therapy

    by Giovanni Frongia, Ji-Oun Byeon, Arianeb Mehrabi, Patrick Günther

    Oral propranolol is the treatment of choice for infantile hemangiomas. The growth relapse rate following oral propranolol therapy is not well established in the literature. The present study aimed at determining predictors of growth relapse of infantile hemangiomas after discontinuation of oral propranolol therapy. A retrospective analysis was performed of all cases of infantile hemangiomas aged ≤ 12 months undergoing oral propranolol therapy in a 6-year period. Of the 198 cases, regrowth after oral propranolol therapy was observed in 35 patients (18%). Facial hemangiomas showed a higher (p = 0.003) relapse rate as compared with other hemangiomas (27 out of 107 facial cases vs. 8 out of 91 with other location, respectively 25% and 8.8%). Of 35 growth relapses cases, 66% of cases (23 in total, 18 facial and 5 otherwise located hemangiomas) underwent a second cycle of oral propranolol therapy (median length of treatment 3 months, interquartile range 2–3). All cases had a successful outcome, either after a single cycle oral propranolol therapy (163 cases, 82%), or in case of regrowth, after a second therapy cycle (23 cases, 12%) or further conservative management (12 cases, 6%). Conclusion: Facial infantile hemangiomas relapse earlier and more frequently after oral propranolol therapy. We suggest to closely monitor these patients, as a second cycle of propranolol may be indicated. Prolonged oral propranolol therapy might be considered for facial infantile hemangiomas. What is Known: • Oral propranolol is the treatment of choice for infantile hemangiomas. • The growth relapse rate following oral propranolol is not well established. What is New: • The present study points out that facial infantile hemangioma relapse earlier and more frequently after oral propranolol therapy. • Patients with facial infantile hemangiomas should be monitored after propranolol therapy discontinuation.


  • Open Access

    Food fear, quick satiety and vomiting in a 16 years old girl

    by Giovanni Frongia, Jens-Peter Schenk, Anja Schaible, Peter Sauer, Arianeb Mehrabi, Patrick Günther

    Introduction: Wilkie’s syndrome (WS), also known as superior mesenteric artery syndrome, is a rare clinical entity caused by compression of the horizontal (third) part of the duodenum between the superior mesenteric artery and the abdominal aorta leading to duodenal obstruction. Presentation of case: We report a case of a 16 years girl with long-term history of spontaneous vomiting and self-induced vomiting, also suffering from recurrent retrosternal pain, weight loss and thus reduced quality of life. Contrast intestinal series showed a large axial hernia which was laparoscopically reduced and treated by hiatoplasty and anterior hemifundoplication. After initial relief, recurrent postprandial nausea and vomiting reoccurred 4 weeks postoperatively. Abdominal MRI study revealed findings compatible with WS. After endoscopic exclusion of an anatomical duodenal lumen stenosis, she was successfully treated by duodeno-jejunostomy with a favorable outcome. Discussion: WS might be hidden behind presumably more evident diagnoses such as bulimia, significant axial hernia and gastro-esophageal reflux disease in patients with recurred vomiting, abdominal pain and weight loss. Conclusion: The rare clinical entity of a WS necessitates a targeted diagnostic evaluation and therapy. Clinical details, diagnostic studies and treatment are discussed here. Highlights:


  • Cardiac diagnostics before oral propranolol therapy in infantile hemangioma: retrospective evaluation of 234 infants

    by Giovanni Frongia, Ji-Oun Byeon, Raoul Arnold, Arianeb Mehrabi, Patrick Günther

    The indication and extent of cardiac screening before oral propranolol therapy (OPT) in patients with infantile hemangioma (IH) has been challenged. In this study, we evaluated pre-OPT cardiac diagnostics in a pediatric IH cohort in our department.


  • The optimal intestinal segment length for experimental size‐mismatched intestinal transplantation: Defining the maximum length with the lowest blood flow needs in a porcine model

    by Giovanni Frongia, Ali Majlesara, Arash Saffari, Golnaz Emami, Mohammad Golriz, Patrick Günther, Arianeb Mehrabi

    Transplanted Intestinal Segments (IS) must match the perfusion capacities of the recipient. This can be challenging during a size‐mismatched SBTX. In this study, we defined the maximum IS length with lowest blood flow needs in a porcine model by evaluating the physiological perfusion rates of different IS lengths. Blood flow in the SMA, aorta segment four, and general circulatory parameters were monitored before and after sequential intestinal resection. IS lengths of 30 cm, 60 cm, 120 cm, and 300 cm (n = 8 each) were compared. The IS blood flow requirements increased with IS length (30 cm: 19.5 ± 3.4 mL/min; 60 cm: 16.9 ± 6.7 mL/min; 120 cm: 34.9 ± 8.5 mL/min; 300 cm: 62.9 ± 11.6 mL/min). Absolute IS blood flow (P = .004), percentage IS blood flow uptake from the SMA (P = .001), and percentage IS blood flow uptake from the aorta (P = .005) increased significantly between 60 cm and 120 cm. We concluded that 60 cm was the maximum IS length before blood flow demands significantly increased in a porcine model.